Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
Journal of the International AIDS Society|December 28, 2013
Antiretroviral treatment and quality of life in Africans living with HIV: 12-month follow-up in Burkina FasoAntoine Jaquet, Franck Garanet, Eric Balestre, et al.
JCO Global Oncology|May 27, 2021
Changes in HIV-Related Cervical Cancer Over a Decade in Côte d'IvoireAntoine Jaquet, Simon Boni, Boris Tchounga, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 1, 2017
Hepatitis B treatment eligibility in West Africa: Uncertainties and need for prospective cohort studiesAntoine Jaquet, Marcellin Nouaman, Judicaël Tine, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|September 5, 2019
Assessment of the scale-up of cervical cancer screening in Abidjan stratified by HIV statusSimon Boni, Boris Tchounga, Kouassi Comoe, et al.
Journal of the International AIDS Society|April 1, 2017
Alcohol use, viral hepatitis and liver fibrosis among HIV-positive persons in West Africa: a cross-sectional studyAntoine Jaquet, Gilles Wandeler, Marcellin Nouaman, et al.
AIDS and Behavior|May 9, 2026
Living in Fear: Severe HIV-Associated Stigma Persists in Senegal, West AfricaNoelle A Benzekri, Astou Diagne, Marie Diouf, et al.
BMC Health Services Research|April 12, 2014
Cervical cancer prevention in reproductive health services: knowledge, attitudes and practices of midwives in Côte d'Ivoire, West AfricaBoris K Tchounga, Antoine Jaquet, Patrick A Coffie, et al.
BMJ Open|September 2, 2019
Cervical cancer screening uptake and correlates among HIV-infected women: a cross-sectional survey in Côte d'Ivoire, West AfricaBoris Tchounga, Simon Pierre Boni, Jean Jacques Koffi, et al.
Plos One|March 6, 2014
Risk factors for cervical intraepithelial neoplasia in HIV-infected women on antiretroviral treatment in Côte d'Ivoire, West AfricaAntoine Jaquet, Apollinaire Horo, Didier K Ekouevi, et al.
Medrxiv : the Preprint Server for Health Sciences|July 2, 2024
HIV-1 subtype-specific drug resistance on dolutegravir-based antiretroviral therapy: protocol for a multicentre longitudinal study (DTG RESIST)Matthias Egger, Mamatha Sauermann, Tom Loosli, et al.
Pageof 9